|
|
 |
|
|
|
| |
Press Releases
| All Releases |
|---|
 |
Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance
May 9, 2008
|
|
| |
ST. DAVID'S, Bermuda, May 9, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) today announced its results for the quarter ended March 31, 2008. Revenue in the quarter ended March 31, 2008 totaled $229.5 million, an increase of 5.1%, over the prior year quarter. The primary drivers of the increase in reve...
|
|
|
Warner Chilcott Announces Settlement of Securities Litigation
Apr 29, 2008
|
|
| |
ST. DAVID'S, Bermuda, April 29, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) today announced that it has reached an agreement in principle to settle a securities class action lawsuit pending in the United States District Court for the Southern District of New York. The suit asserted claims under the ...
|
|
|
Warner Chilcott Announces Earnings Release Date and Conference Call for First Quarter 2008 Financial Results
Apr 22, 2008
|
|
| |
ST. DAVID'S, Bermuda, April 22, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will issue its first quarter 2008 financial results prior to the market opening on Friday, May 9, 2008.
In addition to issuing a press release, the Company will host a conference call for all inte...
|
|
|
Warner Chilcott Reports the Death of Its Director James Andress
Mar 14, 2008
|
|
| |
ST. DAVID'S, Bermuda, March 14, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- It is with a profound sense of loss that Warner Chilcott Limited (Nasdaq: WCRX) reports today that Mr. James G. Andress, a director of the Company, died on Tuesday, March 11, 2008.
Roger Boissonneault, Chief Executive Officer, President and Director of Warner...
|
|
|
Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007
Feb 29, 2008
|
|
| |
ST. DAVID'S, Bermuda, Feb 29, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) today announced its results for the quarter and year ended December 31, 2007. Revenue in the quarter ended December 31, 2007 totaled $227.7 million, an increase of 10.3%, over the prior year quarter. Revenue for the year ended...
|
|
|
Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results
Feb 13, 2008
|
|
| |
ST. DAVID'S, Bermuda, Feb 13, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will issue its fourth quarter and full year 2007 financial results prior to the market opening on Friday, February 29, 2008.
In addition to issuing a press release, the Company will host a conferenc...
|
|
|
Warner Chilcott Announces 2008 Financial Guidance
Jan 28, 2008
|
|
| |
ST. DAVID'S, Bermuda, Jan 28, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today a view of anticipated full year 2008 results.
Total revenues for 2008 are expected to be in the range of $935 to $945 million, with the growth primarily being driven by LOESTRIN 24 FE, DORYX, FEMCON FE, and...
|
|
|
Warner Chilcott to Present at the 2008 Wachovia Healthcare Conference
Jan 24, 2008
|
|
| |
ST. DAVID'S, Bermuda, Jan 24, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will present at the 2008 Wachovia Healthcare Conference on Wednesday, January 30, 2008 at 10:15 a.m. EST. Presenting for Warner Chilcott will be Paul Herendeen, Executive Vice President and Chief Financ...
|
|
|
Warner Chilcott Announces 2008 Financial Guidance Conference Call
Jan 22, 2008
|
|
| |
ST. DAVID'S, Bermuda, Jan 22, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will issue its 2008 Financial Guidance prior to the market open on Monday, January 28, 2008. In addition to issuing a press release, Paul Herendeen, Executive Vice President and Chief Financial Officer ...
|
|
|
Warner Chilcott to Present at the 26th Annual JPMorgan Healthcare Conference
Jan 7, 2008
|
|
| |
ST. DAVID'S, Bermuda, Jan 07, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will present at the 26th Annual JPMorgan Healthcare Conference on Wednesday, January 9, 2008 at 3:00 p.m. Pacific Standard Time. Presenting for Warner Chilcott will be Paul Herendeen, Executive Vice Pre...
|
|
|
Warner Chilcott to Present at the 2008 Morgan Stanley Pharmaceutical CEO's Unplugged Conference
Jan 2, 2008
|
|
| |
ST. DAVID'S, Bermuda, Jan 02, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will present at the Morgan Stanley Pharmaceutical CEO's Unplugged Conference on Friday, January 4, 2008 at 2:30 p.m. EST. Presenting for Warner Chilcott will be Roger Boissonneault, President and Chief ...
|
|
|
Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007
Nov 9, 2007
|
|
| |
ST. DAVID'S, Bermuda, Nov 09, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) today announced its results for the quarter ended September 30, 2007. Revenue in the quarter ended September 30, 2007 totaled $226.5 million, an increase of 16.3%, over the prior year quarter. The primary drivers of the increa...
|
|
|
Warner Chilcott Announces Settlement of Remaining Class Action Suit Brought by Direct Purchasers
Nov 8, 2007
|
|
| |
ST. DAVID'S, Bermuda, Nov 08, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it has reached a tentative settlement to conclude the one remaining antitrust lawsuit involving one of the Company's combined hormonal contraceptives, Ovcon 35. Under the proposed settlement, all claims wi...
|
|
|
Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction
Nov 1, 2007
|
|
| |
FAJARDO, Puerto Rico and EAST WINDSOR, N.J., Nov 01, 2007 /PRNewswire via COMTEX News Network/ -- FAJARDO, Puerto Rico and EAST WINDSOR, N.J., Nov. 1 /PRNewswire-FirstCall/ -- Warner Chilcott Company, Inc. (a subsidiary of Warner Chilcott, Ltd., [Nasdaq: WCRX]) and NexMed, Inc. (Nasdaq: NEXM), announced today that the two companies have entered int...
|
|
|
Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
Oct 29, 2007
|
|
| |
FAJARDO, Puerto Rico and CORONA, Calif., Oct 29, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Company, Inc. and Watson Pharmaceuticals, Inc. announced today that under a supply agreement between Warner Chilcott and Watson Pharma, Inc., Watson has launched Tilia(TM) Fe (norethindrone acetate and ethinyl estradiol tablets, U...
|
|
|
Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2007 Financial Results
Oct 18, 2007
|
|
| |
HAMILTON, Bermuda, Oct 18, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will release its third quarter 2007 financial results prior to the market opening on Friday, November 9, 2007.
The Company will host an investor conference call and an audio webcast on Friday, November...
|
|
|
Warner Chilcott Files Lawsuit Against Watson Laboratories, Inc. for Infringement of FEMCON FE Patent
Oct 1, 2007
|
|
| |
HAMILTON, Bermuda, Oct 01, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that its subsidiary, Warner Chilcott Company, Inc., has filed a lawsuit against Watson Laboratories, Inc. ("Watson") in the District Court for the District of New Jersey for infringement of the Company's U.S. Pate...
|
|
|
Warner Chilcott Files Lawsuit Against Barr Laboratories, Inc. for Infringement of FEMCON FE Patent
Sep 24, 2007
|
|
| |
HAMILTON, Bermuda, Sept 24, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that its subsidiary, Warner Chilcott Company, Inc., has filed a lawsuit against Barr Laboratories, Inc. ("Barr") in the District Court for the District of New Jersey for infringement of the Company's U.S. Patent ...
|
|
|
Warner Chilcott to Present at the 2007 UBS Global Life Sciences Conference
Sep 19, 2007
|
|
| |
HAMILTON, Bermuda, Sept 19, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will present at the 2007 UBS Global Life Sciences Conference on Monday, September 24, 2007 at 2:30 p.m. EDT. Presenting for Warner Chilcott will be Paul Herendeen, Executive Vice President and Chief Finan...
|
|
|
Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
Sep 17, 2007
|
|
| |
HAMILTON, Bermuda, Sept 17, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today that LEO Pharma A/S ("LEO") has received a non-final Action Closing Prosecution from the U.S. Patent and Trademark Office (the "USPTO"). In September 2006, the USPTO ordered a reexamination of LEO's US Patent No....
|
|
|
= Add Release to Briefcase
|
|
|
|
|
| Stock Information |
NASD:WCRX
$16.90
- 0.61
|
May 9, 2008
3:44 PM ET |
Quotes delayed by approximately 20 minutes. Information provided by TurboFeed. |
Need Adobe® Acrobat® Reader?
|
|
|
